Cell-wall deficient mycobacteria in the pathogenesis of sarcoidosis

R. M. Rutherford, J. Flynn, J. J. Gilmartin (Galway, Ireland)

Source: Annual Congress 2001 - Molecular associations with TB
Session: Molecular associations with TB
Session type: Thematic Poster Session
Number: 2042
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. M. Rutherford, J. Flynn, J. J. Gilmartin (Galway, Ireland). Cell-wall deficient mycobacteria in the pathogenesis of sarcoidosis. Eur Respir J 2001; 16: Suppl. 31, 2042

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impaired host defense against Mycobacterium avium in mice with chronic granulomatous disease
Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Year: 2008


Cytokines in pathogenesis of pulmonary tuberculosis
Source: Annual Congress 2011 - Tuberculosis: from bench to bedside
Year: 2011

Clinical relevance of Mycobacterium simiae in pulmonary samples
Source: Eur Respir J 2008; 31: 106-109
Year: 2008



The immunogenetic spectrum of susceptibility to mycobacteria: from granulomatous hypersensitivity to infection
Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases
Year: 2009

Characteristics of mycobacterial strains isolated from immunocompetent and immunosuppressed patients with particular forms of tuberculosis
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007


Role of cytokines in the immunopathogenesis of the MDR pulmonary tuberculosis
Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2008

Susceptibility to nontuberculous mycobacterial lung disease
Source: Eur Respir J 2008; 31: 1322-1333
Year: 2008



The role of genexpert in the diagnosis of mycobacterium tuberculosis
Source: International Congress 2019 – Tuberculosis: diagnosis
Year: 2019


Deficient interleukin-17 production in response to Mycobacterium abscessus in cystic fibrosis
Source: Eur Respir J 2016; 47: 990-993
Year: 2016


Nontuberculous mycobacterial disease in CF
Source: ERS course 2015
Year: 2015

The attenuation of cytokine response might be correlated with gut dysbiosis in nontuberculous mycobacteria lung disease
Source: International Congress 2019 – Tuberculosis: from basic science to patient care
Year: 2019

Non-tuberculous mycobacterial pulmonary disease
Source: Eur Respir J, 54 (1) 1900250; 10.1183/13993003.00250-2019
Year: 2019



Nontuberculous mycobacterial infections
Source: Eur Respir Mon 2011; 52: 115-129
Year: 2011


Atypical manifestations of mycobacterium tuberculosis infection
Source: Eur Respir J 2004; 24: Suppl. 48, 647s
Year: 2004

Pulmonary nontuberculous mycobacterial diseases
Source: ERS Course 2019 - Summer school of adult respiratory medicine
Year: 2019

Pulmonary nontuberculous mycobacterial diseases
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017

Pulmonary nontuberculous mycobacterial diseases
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018

Immune defects in patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis
Source: ERJ Open Res, 6 (4) 00590-2020; 10.1183/23120541.00590-2020
Year: 2020



Nontuberculous mycobacteria infection in patients with cystic fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 615s
Year: 2004